WO2025229405 - METHODS FOR SELECTING AND TREATING PATIENTS WITH RETINAL DISEASE BASED ON COMPLEMENT PATHWAY HYPERACTIVITY
National phase entry is expected:
Publication Number
WO/2025/229405
Publication Date
06.11.2025
International Application No.
PCT/IB2025/000205
International Filing Date
02.05.2025
Title **
[English]
METHODS FOR SELECTING AND TREATING PATIENTS WITH RETINAL DISEASE BASED ON COMPLEMENT PATHWAY HYPERACTIVITY
[French]
PROCÉDÉS DE SÉLECTION ET DE TRAITEMENT DE PATIENTS ATTEINTS D'UNE MALADIE RÉTINIENNE SUR LA BASE D'UNE HYPERACTIVITÉ DE LA VOIE DU COMPLÉMENT
Applicants **
OAK BAY BIOSCIENCES INC.
Inventors
ERICKSON, Carl
Priority Data
63/642,557
03.05.2024
US
63/756,476
10.02.2025
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CIPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5610 | |
| EPO | Filing, Examination, Granting | 130947 | |
| Japan | Filing, Examination, Granting | 4943 | |
| South Korea | Filing, Examination, Granting | 9603 | |
| USA | Filing, Examination, Granting | 28940 |
Total:
180,043
Contact Us
Abstract[English]
Provided herein are methods of treating a subject with a complement pathway inhibitor based on the subject's complement pathway activity. Also provided herein are methods of stratifying a subject into three groups based on the subject's complement pathway activity: hyperactive, homeostatic, and hypoactive, and administering an effective treatment (e.g., complement pathway inhibitors).[French]
L'invention concerne des procédés de traitement d'un sujet avec un inhibiteur de la voie du complément sur la base de l'activité de la voie du complément du sujet. L'invention concerne également des procédés de stratification d'un sujet en trois groupes sur la base de l'activité de la voie du complément du sujet : hyperactive, homéostatique et hypoactive, et d'administration d'un traitement efficace (par exemple, des inhibiteurs de la voie du complément).